Doxazosin Tablet
Product Images NDC 68071-3341

The text contains information about a pharmaceutical product called Doxazosin 2mg, including lot number, NDC number, manufacturer information, expiration date, and serial number. It also provides a warning to keep the product out of reach of children and store it at a controlled temperature of 68-77°F. The text suggests contacting a doctor for medical advice regarding side effects and mentions reporting any side effects to the FDA.*

The text provides information on the mean change in total symptom score and mean increase in maximum urinary flow rate from baseline, measured in mL/sec. It also mentions the duration of treatment in weeks. Additionally, there are symbols indicating statistical significance in comparison to placebo and baseline, as well as the mention of doxazosin titration to a maximum of 8 mg.*

This is a summary of effectiveness data from placebo-controlled trials comparing doxazosin at different doses to placebo in the treatment of benign prostatic hyperplasia (BPH). The text includes information on maximum flow rate, symptom scores, and questionnaires used in the studies. Data from three separate studies are presented, each with its own set of baseline and change measurements for the different treatment groups. Study 2 appears to focus on the maximum flow rate, with measurements provided for different doses of doxazosin compared to placebo. Overall, the text provides details on the efficacy of doxazosin in improving symptoms related to BPH compared to placebo.*